These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Influence of intravenous infusions of hydroxyethylstarch (HES) (MW 40,000 and 450,000) on the blood flow properties of healthy volunteers. Ehrly AM; Landgraf H Angiology; 1985 Jan; 36(1):41-4. PubMed ID: 2411169 [TBL] [Abstract][Full Text] [Related]
9. Action of hydroxyethyl starch on the flow properties of human erythrocyte suspensions. Corry WD; Jackson LJ; Seaman GV Biorheology; 1983; 20(5):705-17. PubMed ID: 6203575 [TBL] [Abstract][Full Text] [Related]
10. [Hemorheologic and circulatory effects of hemodilution with medium molecular weight hydroxyethyl starch in two concentrations (HAES 200/0.62 10% and 6%)]. Jung F; Waldhausen P; Spitzer S; Wenzel E Acta Med Austriaca; 1991; 18 Suppl 1():9-15. PubMed ID: 1719736 [TBL] [Abstract][Full Text] [Related]
11. [Comparison of 2 6% middle-molecular hydroxyethyl starch solutions on elimination kinetics and flow characteristics of blood in volunteers]. Koscielny J; Jung F; Mrowietz C; Pindur G; Förster H; Schimetta W; Kiesewetter H; Wenzel E Infusionsther Transfusionsmed; 1994 Aug; 21(4):251-9. PubMed ID: 7524833 [TBL] [Abstract][Full Text] [Related]
12. [Rheological and expander effect of hydroxyethyl-starch in intradural anesthesia]. González de Zárate Apiñaniz J; Catón Valdés MM; Alvarez López JC; Vega Sánchez JM; Ojeda Ortego J Rev Esp Anestesiol Reanim; 1991; 38(2):90-3. PubMed ID: 1715092 [TBL] [Abstract][Full Text] [Related]
13. [Continuous hemodilution using a low-molecular hydroxyethyl starch solution. Pilot studies in patients with acute cerebral ischemia]. Fuchs M; Henkel P; Becker-Scheid D; Schmitt J Infusionstherapie; 1990 Aug; 17(4):205-9. PubMed ID: 1698719 [TBL] [Abstract][Full Text] [Related]
14. [Conjunctival oxygen partial pressure, hemorheology and circulatory parameters in acute cerebral infarct before and following infusion of 6 percent low molecular hydroxyethyl starch]. Kortsik CS; Staedt U; Stein T; Geiger G; Buss J Infusionstherapie; 1990 Apr; 17(2):79-82. PubMed ID: 1693909 [TBL] [Abstract][Full Text] [Related]
15. Hypervolumetric hemodilution with HES 100/0.5 10% in patients with peripheral arterial occlusive disease (Fontaine, stage II): an open clinical and pharmacological phase IV study. Koscielny J; Latza R; Pruss A; Kiesewetter H; Jung F; Meier C; Schimetta W Clin Hemorheol Microcirc; 2000; 22(1):53-65. PubMed ID: 10711822 [TBL] [Abstract][Full Text] [Related]
16. [Middle-molecular hydroxyethyl starch as a volume substitute. Its rheological effect in peripheral arterial occlusive diseases]. Kiesewetter H; Blume J; Bulling B; Gerhards M; Jung F; Radtke H; Franke RP Dtsch Med Wochenschr; 1984 Nov; 109(48):1844-7. PubMed ID: 6209081 [TBL] [Abstract][Full Text] [Related]
17. [The effect of molecular structure of hydroxyethyl starch on the elimination kinetics and fluidity of blood in human volunteers]. Jung F; Koscielny J; Mrowietz C; Förster H; Schimetta W; Kiesewetter H; Wenzel E Arzneimittelforschung; 1993 Feb; 43(2):99-105. PubMed ID: 7681289 [TBL] [Abstract][Full Text] [Related]
18. Effects of polyethylene glycol and hydroxyethyl starch in University of Wisconsin preservation solution on human red blood cell aggregation and viscosity. Mosbah IB; Franco-Gou R; Abdennebi HB; Hernandez R; Escolar G; Saidane D; Rosello-Catafau J; Peralta C Transplant Proc; 2006 Jun; 38(5):1229-35. PubMed ID: 16797270 [TBL] [Abstract][Full Text] [Related]
19. [Degree of substitution and volume expanding effect of various medium molecular weight hydroxyethyl starch solutions]. Kröll W; Pölz W; Colombo T; Steindorfer P Wien Klin Wochenschr; 1994; 106(13):416-21. PubMed ID: 7522379 [TBL] [Abstract][Full Text] [Related]
20. The effect of hydroxyethyl starch on the rheological properties of human erythrocyte suspensions. Corry WD; Jackson LJ; Seaman GV Biorheology; 1981; 18(3-6):517-29. PubMed ID: 6173080 [No Abstract] [Full Text] [Related] [Next] [New Search]